Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2021-05-17

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$366.7m reported value +9.4% vs Q4 2020
15positions
89.3%in top 10
1 new 11 added 1 reduced 1 sold out vs Q4 2020

Options: 0 call positions (— notional), 2 put positions ($186.7m notional) – listed below, not included above.

Holdings, Q1 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPERO THERAPEUTICS INC COM SPRO SPRO 3,829,209 $56.4m15.37% 15.37% ReducedShares held: Q2 2020 1.9m, Q3 2020 4.5m, Q4 2020 3.9m, Q1 2021 3.8m -103.0k -103,000 -2.6%
2 DICERNA PHARMACEUTICALS INC COM DRNA DRNA 1,705,392 $43.6m11.89% 11.89% AddedShares held: Q2 2020 1.5m, Q3 2020 1.4m, Q4 2020 1.4m, Q1 2021 1.7m +350.0k +350,000 25.8%
3 BLUEPRINT MEDICINES CORP COM BPMC BPMC 423,012 $41.1m11.22% 11.22% AddedShares held: Q2 2020 315.0k, Q3 2020 385.7k, Q4 2020 380.0k, Q1 2021 423.0k +43.0k +43,000 11.3%
4 NGM BIOPHARMACEUTICALS INC COM NGM NGM 1,124,237 $32.7m8.91% 8.91% AddedShares held: Q2 2020 1.1m, Q3 2020 1.0m, Q4 2020 1.0m, Q1 2021 1.1m +118.7k +118,703 11.8%
5 HARPOON THERAPEUTICS INC COM COM 1,554,199 $32.5m8.87% 8.87% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 1.6m
6 UNIQURE NV SHS QURE QURE 955,424 $32.2m8.78% 8.78% AddedShares held: Q2 2020 679.6k, Q3 2020 631.1k, Q4 2020 702.0k, Q1 2021 955.4k +253.4k +253,374 36.1%
7 MAGENTA THERAPEUTICS INC COM COM 2,502,210 $29.6m8.08% 8.08% AddedShares held: Q2 2020 0, Q3 2020 958.6k, Q4 2020 2.3m, Q1 2021 2.5m +235.8k +235,787 10.4%
8 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 407,926 $27.1m7.38% 7.38% AddedShares held: Q2 2020 563.3k, Q3 2020 523.4k, Q4 2020 365.9k, Q1 2021 407.9k +42.0k +42,000 11.5%
9 REGENXBIO INC COM RGNX RGNX 559,444 $19.1m5.20% 5.20% AddedShares held: Q2 2020 553.5k, Q3 2020 510.8k, Q4 2020 503.4k, Q1 2021 559.4k +56.0k +56,000 11.1%
10 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 300,886 $13.1m3.56% 3.56% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 20.0k, Q1 2021 300.9k +280.9k +280,886 1404.4%
11 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 800,000 $11.1m3.04% 3.04% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 800.0k, Q1 2021 800.0k
12 PIERIS PHARMACEUTICALS INC COM COM 3,675,530 $9.4m2.58% 2.58% UnchangedShares held: Q2 2020 5.6m, Q3 2020 3.7m, Q4 2020 3.7m, Q1 2021 3.7m
13 GALAPAGOS NV SPON ADR LKFT LKFT 116,723 $9.0m2.45% 2.45% AddedShares held: Q2 2020 44.2k, Q3 2020 32.5k, Q4 2020 70.0k, Q1 2021 116.7k +46.7k +46,734 66.8%
14 ARGENX SE SPONSORED ADR ARGX ARGX 21,200 $5.8m1.59% 1.59% AddedShares held: Q2 2020 35.8k, Q3 2020 7.5k, Q4 2020 12.7k, Q1 2021 21.2k +8.5k +8,500 66.9%
15 GENMAB A/S SPONSORED ADS GMAB GMAB 120,000 $3.9m1.07% 1.07% AddedShares held: Q2 2020 0, Q3 2020 50.0k, Q4 2020 90.0k, Q1 2021 120.0k +30.0k +30,000 33.3%

Sold out since Q4 2020

SecurityTickerShares held beforeValue then
ANAPTYSBIO INC ANAB ANAB 1,215,958 $26.1m1.2m shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 300,000 $118.9m300.0k shares New
SPDR SER TR XBI · Put XBIPut 500,000 $67.8m500.0k shares Unchanged

Trades reported as a company insider in Q1 2021

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2021-02-08 SPERO THERAPEUTICS INC 10% owner · See Footnote SPRO Sold 3,000 $65.2k3.0k shares -<1%
2021-02-04 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Sold 34,144 $648.4k34.1k shares -1%
2021-02-03 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Sold 29,354 $557.1k29.4k shares -1%
2021-02-02 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Sold 22,841 $433.8k22.8k shares -1%
2021-02-01 SPERO THERAPEUTICS INC 10% owner · See Footnotes SPRO Sold 13,661 $262.8k13.7k shares -<1%